Figure 3

Cytotoxic effect of tk-VLPs on human DLBCL cells. The viability of DLBCL cells at different days after various treatments was assessed by the MTT assay. The treatment combinations included PBS followed by PBS (PBS/PBS), PBS followed by GCV (PBS/GCV), control VLPs followed by GCV (VLP/GCV), the pUMVC1‐tk plasmid followed by GCV (tk/GCV), tk-VLPs followed by PBS (tk‐VLP/PBS) and tk-VLPs followed by GCV (tk-VLP/GCV).